NWM
CLX icon

Northcape Wealth Management’s Clorox CLX Stock Holding History

Northcape Wealth Management’s Portfolio CLX Stock Details CLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-2,104
Closed -$259K – 140
2025
Q3 		$259K Sell
2,104
-2
-0.1% -$248 0.08% 127
2025
Q2 		$253K Buy
2,106
+133
+7% +$17.7K 0.08% 128
2025
Q1 		$291K Hold
1,973
– – 0.09% 120
2024
Q4 		$320K Buy
1,973
+31
+2% +$5.07K 0.1% 113
2024
Q3 		$316K Sell
1,942
-151
-7% -$22.4K 0.1% 111
2024
Q2 		$286K Buy
2,093
+400
+24% +$55.5K 0.1% 112
2024
Q1 		$259K Sell
1,693
-400
-19% -$59.7K 0.09% 119
2023
Q4 		$298K Hold
2,093
– – 0.11% 117
2023
Q3 		$274K Sell
2,093
-10
-0.5% -$1.52K 0.11% 123
2023
Q2 		$334K Hold
2,103
– – 0.12% 120
2023
Q1 		$333K Buy
+2,103
New +$315K 0.12% 120
2022
Q4 		– Sell
-4,848
Closed -$622K – 84
2022
Q3 		$622K Buy
4,848
+2,990
+161% +$431K 0.22% 82
2022
Q2 		$262K Sell
1,858
-2,885
-61% -$412K 0.1% 106
2022
Q1 		$659K Buy
4,743
+2,942
+163% +$451K 0.19% 88
2021
Q4 		$314K Buy
+1,801
New +$300K 0.11% 102

Other funds holding CLX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Northcape Wealth Management's CLX Position: Q4 2025 in Review

Northcape Wealth Management sold out of Clorox (CLX) in Q4 2025, closing a stake of 2,104 shares — an estimated $259K sold.

Northcape Wealth Management first reported a position in CLX in Q4 2021 and held it in 15 quarters. The position peaked at $659K in Q1 2022. 1,052 funds tracked by Wall St. Rank hold CLX as of Q4 2025.

  • Northcape Wealth Management reported no remaining Clorox position as of Q4 2025 after selling out during the quarter.
  • Northcape Wealth Management sold 2,104 Clorox shares in Q4 2025, an estimated $259K.
  • Northcape Wealth Management first reported a position in Clorox in Q4 2021 and held it in 15 quarters.
  • Northcape Wealth Management's Clorox position peaked at $659K in Q1 2022.
  • 1,052 funds tracked by Wall St. Rank held Clorox as of Q4 2025.

Based on Northcape Wealth Management's 13F filing for Q4 2025, filed 22 Jan 2026.